We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Start of NIH-Sponsored Study of Iron Therapy Drug
FDA Approves Start of NIH-Sponsored Study of Iron Therapy Drug
December 4, 2007
Rockwell Medical Technologies, Inc., a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate products, reported that the FDA has approved initiation of a National Institutes of Health (NIH) sponsored clinical study for Rockwell’s proprietary drug-delivery product SFP for chronic hemodialysis patients. CNN Money
